Pipeline

2021 status

PROGRAM

DISEASE

DISCOVERY

DEVELOPMENT

PHASE 1B

PHASE 2

PHASE 3

Memory NK

AML, MDS

WU-NK-101

WU-NK

WU-NK-101

Solid Tumors

WU-NK-201
WU-CART-007

WU-CART

T-ALL, T-NHL

WU-CART-002
WU-ALLO-1

WU-ALLO 

AML, MDS

WU-ALLO-2
WU-ALLO-3

AML = Acute Myeloid Leukemia
MDS = Myelodysplastic syndrome
T-ALL = T-cell Acute Lymphoblastic Leukemia
T-NHL = T-cell Non-Hodgkin’s Lymphoma

Next in our story
Scroll to Top